Ordering Recommendation

Prenatal test for fetuses of mothers with fragile X premutations or full mutations.

Maternal cell contamination (MCC) analysis is required and performed at no additional charge. Order Maternal Cell Contamination, Maternal Specimen (0050608) on a maternal blood specimen.

For guidance on ordering maternal cell contamination studies, please refer to Maternal Cell Contamination (MCC) Analysis Guide.  

New York DOH Approval Status

This test is New York state approved.

Specimen Required

Patient Preparation
Collect

Fetal Specimen: Cultured amniocytes.
Maternal Specimen: Refer to Maternal Cell Contamination, Maternal Specimen (0050608) for maternal specimen requirements.

Specimen Preparation

Transport: Two T-25 flasks of 80% confluent cultured amniocytes. Cultured amniocytes are required for testing. If submitting uncultured (direct) amniotic fluid and testing is desired on a cultured specimen, add Cell Culture for Genetic Testing (3020627). If transporting flasks, the client is responsible for maintaining backup cultures at the client institution. If ARUP receives cultured fetal cells below minimum confluence, Cell Culture for Genetic Testing (3020627) will be added by ARUP.

Storage/Transport Temperature

Preferred transport: Room temperature.
Preferred shipment: Within two days of collection or confluence.

Unacceptable Conditions

Frozen specimens.

Remarks

Methylation patterns may not be fully established in early gestation; thus, methylation testing performed on chorionic villus samples may not distinguish between premutation and full mutation alleles.
Counseling and informed consent are recommended for genetic testing. Consent forms are linked above.
New York Clients: informed consent is required with submission.

Stability

Room temperature: 2 days; Refrigerated: Unacceptable; Frozen: Unacceptable

Methodology

Polymerase Chain Reaction (PCR) / Capillary Electrophoresis

Performed

Varies

Reported

9-10 days
If culture is required, an additional 1 to 2 weeks is required for processing time.

Reference Interval

Refer to report

Interpretive Data

Refer to report.


Phenotype Number of CGG Repeats
Unaffected < 45
Intermediate 45-54
Premutation 55-200
Affected >200

Compliance Category

Laboratory Developed Test (LDT)

Note

If a CGG repeat of 100 or greater is detected by PCR and capillary electrophoresis, methylation analysis will be added. Additional charges apply.

Hotline History

N/A

CPT Codes

81243; 81265 Fetal Cell Contamination (FCC); if reflexed, add 81244

Components

Component Test Code* Component Chart Name LOINC
0050548 Maternal Contamination Study Fetal Spec 59266-7
0050556 Fragile X Allele 1 45321-7
0050558 Fragile X Allele 2 45322-5
0050559 Fragile X Methylation Pattern 41107-4
0050612 Maternal Contam Study, Maternal Spec 66746-9
0051389 Fragile X Fetal Specimen 66746-9
2010041 Fragile X Interpretation, Fetal 36914-0
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.

Aliases

  • Cytogenetics, High Resolution & Fragile X DNA (Fragile X (FMR1) Diagnostic, Fetal)
  • High Resolution & Fragile X DNA (Fragile X (FMR1) Diagnostic, Fetal)
  • Inherited Mental Retardation (Fragile X (FMR1) Diagnostic, Fetal)
  • Martin-Bell Syndrome (Fragile X (FMR1) Diagnostic, Fetal)
Fragile X ( FMR1 ) with Reflex to Methylation Analysis, Fetal